Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lenoss Medical
AddedFeb 16, 2024
UpdatedJun 18, 2026
Lenoss Medical

Lenoss Medical

Series A

Lenoss Medical: Innovating spinal fracture treatment with minimally invasive, cement-free technology.

HQ
Providence, RI, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to innovate spinal fracture treatment, Lenoss Medical focuses on providing solutions that support the natural osseous healing process. Their core product, the OsteoPearl VBA system, is a minimally invasive and cement-free technology designed to utilize the natural healing properties of healthy bone. This approach aims to disrupt traditional spinal fracture treatments by offering a viable alternative that promotes better patient outcomes.

Lenoss Medical has garnered attention for its groundbreaking technology and has attracted notable investors and medical advisors who are leaders in the field. Key achievements include the successful development and implementation of the OsteoPearl VBA system, which has shown promising results in clinical settings. The company's impact is significant in advancing spinal fracture treatment, offering patients a more natural and less invasive option for recovery.

Lenoss Medical - Similar Companies

SpineOvations logo

SpineOvations

Minimus Spine logo

Minimus Spine

Osseon Therapeutics logo

Osseon Therapeutics

Crosstrees Medical logo

Crosstrees Medical

Novum Medical logo

Novum Medical

Ouroboros Medical logo

Ouroboros Medical

Spineloop logo

Spineloop

spineloop.com

Vertos Medical logo

Vertos Medical

vertosmed.com

Vertebral Technologies logo

Vertebral Technologies

Spinal Simplicity logo

Spinal Simplicity

Intact Medical logo

Intact Medical

AgNovos Healthcare logo

AgNovos Healthcare

VerteCore logo

VerteCore

Osteovantage logo

Osteovantage

Lineus Medical logo

Lineus Medical

lineusmed.com

Lenoss Medical - Quick Facts

Who are Lenoss Medical's competitors?

Companies similar to Lenoss Medical include SpineOvations, Minimus Spine, Osseon Therapeutics and Crosstrees Medical.

When was Lenoss Medical founded?

Lenoss Medical was founded in 2017.

Where is Lenoss Medical's headquarters located?

Lenoss Medical's headquarters is located in Providence, RI, US.

How much has Lenoss Medical raised to-date?

As of Dec 13, 2023, Lenoss Medical has raised a total of $1.3M (USD).

How many employees does Lenoss Medical have?

Lenoss Medical has 8 employees as of Feb 4, 2024.

Lenoss Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified